Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients

[1]  D. Aronoff,et al.  Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients , 2014, Transplant infectious disease : an official journal of the Transplantation Society.

[2]  N. Beeching,et al.  Serum Mannose-Binding Lectin Concentration, but Not Genotype, Is Associated With Clostridium difficile Infection Recurrence: A Prospective Cohort Study , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  N. Matsuno,et al.  Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study , 2014, Transplant infectious disease : an official journal of the Transplantation Society.

[4]  J. Ballard,et al.  Variations in Virulence and Molecular Biology among Emerging Strains of Clostridium difficile , 2013, Microbiology and Molecular Reviews.

[5]  C. Huff,et al.  Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  J. Mehta,et al.  Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  K. Sepkowitz,et al.  Hospital-Onset Clostridium difficile Infection Rates in Persons with Cancer or Hematopoietic Stem Cell Transplant: A C3IC Network Report , 2012, Infection Control & Hospital Epidemiology.

[8]  R. Porcher,et al.  Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  T. Peto,et al.  Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  C. Huff,et al.  Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  O. Dekkers,et al.  Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. , 2012, The Journal of antimicrobial chemotherapy.

[12]  A. Zinsmeister,et al.  The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study , 2012, The American Journal of Gastroenterology.

[13]  G. Dumyati,et al.  Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  G. Alangaden,et al.  Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation , 2011, Clinical transplantation.

[15]  J. Patterson,et al.  Clinical Predictors and Risk Factors for Relapsing Clostridium difficile Infection , 2010, The American journal of the medical sciences.

[16]  D. Gerding,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) , 2010, Infection Control & Hospital Epidemiology.

[17]  J. Dipersio,et al.  Clostridium difficile‐associated disease in allogeneic hematopoietic stem‐cell transplant recipients: risk associations, protective associations, and outcomes , 2010, Clinical transplantation.

[18]  Stuart Johnson.  Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. , 2009, The Journal of infection.

[19]  K. Garey,et al.  Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. , 2008, The Journal of hospital infection.

[20]  M. Restrepo,et al.  Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma , 2006, Bone Marrow Transplantation.

[21]  D. Milligan,et al.  Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality , 2000, Bone Marrow Transplantation.

[22]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[23]  J. Klein,et al.  IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.